2m 2m 2m 2m 2m 2m 2m
Provectus Biopha (PVCT)
OTC
$0.06+$0.003 (+5.60%)
Price as of Sep 11, 2026- $45.7MMarket Cap
- -17.97%1-Year Change
- BiotechnologyIndustry
Provectus Biopha (PVCT)
$0.06+$0.003 (+5.60%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 30
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.05
$0.06
$0.06
1-Year Range
$0.04
$0.09
$0.06
Latest Close$0.06
Change
+$0.003 (+5.30%)
Volume41,500
Market Cap$45.7M
Shares Outstanding419.5M
P/E (TTM)-14.34
Diluted EPS (TTM)-$0.008
Enterprise Value$54.5M
Information as of 09/11/2026
Company Profile
PROVECTUS BIOPHARMS
$45.7M
Market Cap
-$3.2M
Net Income
Sector: Healthcare
Industry: Biotechnology
PROVECTUS BIOPHARMS
Key Executives
- Dominic Rodrigues
- Edward V. Pershing
- Eric A. Wachter
- Heather Raines
Current Ownership Distribution
- Other395.6M (94.12%)
- Insiders20.4M (4.86%)
- Institutions4.3M (1.02%)
- Mutual Funds0 (0.00%)